Main Session
Sep
29
SS 41 - Optimizing Radiation Therapy in Gynecologic Cancers: Fractionation, Targeting, and Toxicity Reduction
Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study
Presenter(s)
Zheng Zeng, MD - Peking Union Medical College Hospital, Beijing, Beijing